|
Session 155
Poster Abstracts
Hepatic Complications
Tuesday, 1-4 pm
Room: Hall B |
958
 |
Evolution of Non-alcoholic Fatty Liver Disease in HIV-infected Patients: Incidence, Characteristics, and Predictors
Giovanni Guaraldi*1, N Squillace1, C Stentarelli1, G Orlando1, R D'Amico1, G Ligabue1, F Fiocchi1, S Zona1, R Esposito1, and F Palella2
1Univ of Modena and Reggio Emilia, Modena, Italy and 2Feinberg Sch of Med, Northwestern Univ, Chicago, IL, US |
959
|
Exposure to Antiretrovirals and Risk for Advanced Liver Fibrosis: Harmful Effect of Drug-related Metabolic Abnormalities?
Francisco Blanco*, P Barreiro, P Ryan, J Troya, S Arponen, E Vispo, L Martin-Carbonero, P Labarga, J Gonzalez-Lahoz, and V Soriano
Hosp Carlos III, Madrid, Spain |
960
|
Low Hepatoxicity in Patients Randomized to Switching to Nevirapine Once Daily vs Continuing with Nevirapine Twice Daily
Daniel Podzamczer*1, M Olmo1, J Sanz2, V Boix3, B Clotet4, H Knobel5, G Leibenger1, P Domingo6, J Pineda7, C Vilades8, and the NODy Study Group
1Hosp Univ de Bellvitge, Barcelona, Spain; 2Hosp Ppe de Asturias, Madrid, Spain; 3Hosp Gral de Alicante, Alicante, Spain; 4Hosp Germans Trials i Pujol, Badalona, Spain; 5Hosp del Mar, Barcelona, Spain; 6Hosp St Pau, Barcelona, Spain; 7Hosp Valme, Seville, Spain; and 8Hosp Joan XXIII, Tarragona, Spain |
961
|
Liver Histology and Hepatic Mitochondrial Function in HIV-1-infected Patients on ART with Chronic Transaminase Elevation
Marc-Antoine Valantin*1, P Ingiliz1, F Charlotte1, F Mejda2, S Dominguez1, R Tubiana1, C Duvivier3, A Lombes2, Y Benhamou1, and C Katlama1
1Hosp Pitie-Salpetriere, Paris, France; 2Hosp Pitie-Salpetriere, Paris, France; and 3Ctr Hosp Univ Necker, Paris, France |
|
